The Leukemia & Lymphoma Society Co-Pay Assistance Fund Surpasses $100 Million

WHITE PLAINS, N.Y., Dec. 15, 2011 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is proud to announce that it has exceeded the $100 million mark in funds raised for its Co-Pay Assistance Program since its inception in 2007.

(Logo: )

The program provides support for prescription drug co-pays and health insurance premiums for blood cancer patients who meet certain income requirements. Patients with private insurance, Medicare beneficiaries under Medicare Part B and/or Medicare Plan D, Medicare Supplementary Health Insurance and Medicare Advantage are eligible.

"Receiving a diagnosis of a blood cancer is overwhelming and that devastating news can be compounded by an inability to afford the treatments," said John Walter, LLS president and CEO. "LLS's Co-Pay Assistance Program helps alleviate this burden for eligible patients."

Patients, caregivers, pharmacies and healthcare providers can easily submit online Co-Pay applications with a quick registration process, day or night. Your doctor, treatment provider or pharmacy can apply for the program on your behalf.

Visit or call 877-LLS-COPAY to learn more about the program and which diseases are currently covered.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society┬« (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.  

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

Contact: Andrea Greif
(914) 821-8958, (914) 772-3027 (cell)
[email protected]

SOURCE The Leukemia & Lymphoma Society